|
氯吡格雷甲磺酸盐市场分析报告
|
Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... metabolics. Cardiovascular PLAVIX: PLAVIX is a clopidogrel bisulfate, which is a platelet aggregation ... disease or acute coronary syndrome. Clopidogrel bisulfate is jointly marketed with ... therapy, including GLEEVEC (imatinib mesylate), and for the treatment ...
2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... Bromhexine, Bucillamine, Budesonide, Calcifediol, Camostate mesylate, Camrelizumab, Canakinumab , Candesartan, Carrimycin, ... Clazakizumab, CLEVIRA , Clevudine, Clindamycin, Clofazimine, Clopidogrel, Cobicistat, Colchicine, corticosteroid , Cospherunate, CPI ...
COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... Bromhexine, Bucillamine, Budesonide, Calcifediol, Camostate mesylate, Camrelizumab, Canakinumab , Candesartan, Carrimycin, ... Clazakizumab, CLEVIRA , Clevudine, Clindamycin, Clofazimine, Clopidogrel, Cobicistat, Colchicine, corticosteroid , Cospherunate, CPI ...
|
|
|